Objective: The aim of this study was to identify the potential relationships between plasma 25-hydroxyvitamin D 3 (25OHD 3 ), C-reactive protein (CRP), coronary artery atherosclerosis (CAA), and coronary artery remodeling in monkeys consuming atherogenic diets.
I t has been estimated that approximately one third of 40-year-old women in the United States will develop coronary heart disease (CHD). 1 Despite recent declines, CHD remains the number one cause of mortality in women 65 years or older. 2, 3 Furthermore, approximately 64% of women who die of CHD had no prior symptoms. 3 Primary risk factors for CHD in women, as determined by the National Cholesterol Education Program, the American Heart Association, and the American College of Cardiology, include a personal history of CHD, age over 55 years, dyslipidemia, family history of premature CHD, diabetes mellitus, smoking, hypertension, obesity, physical inactivity, the metabolic syndrome, and a personal history of peripheral arterial disease. 2<5 However, the aforementioned risk factors may still underestimate risk in early postmenopausal women. Among young (~55 y of age), nondiabetic postmenopausal women classified as low risk and requiring no further intervention according to their Framingham risk score, approximately 33% have detectable coronary artery calcium indicative of subclinical atherosclerosis. 6 Consequently, additional markers have been evaluated to determine their usefulness as indicators of CHD risk. For example, the inflammatory risk marker C-reactive protein (CRP) has been found to be an independent predictor of future cardiovascular events. 7 In recent years, plasma 25-hydroxyvitamin D (25OHD) has become a topic of major interest in the research community. Although the relationship between 25OHD and bone health is well studied, 8 the current understanding of 25OHD and its direct effect on other physiologic systems is limited. Accordingly, the Institute of Medicine recently reaffirmed the need to advance our knowledge related to 25OHD deficiency and its association with nonskeletal parameters. 8 In addition, it has been well established that inflammation plays an important role in the pathogenesis of cardiovascular disease. 7, 9 Therefore, the assessment of inflammatory markers has been proposed as an approach to improve risk prediction of cardiovascular events. Among the biomarkers of inflammation, CRP seems to have the strongest independent ability to predict cardiovascular events. 9 More than a dozen prospective epidemiological studies have demonstrated that a single, nonfasting measure of CRP is a strong predictor of future cardiovascular events among individuals without a history of cardiovascular disease. 7 Recent studies have suggested that there may be a relationship between plasma 25OHD concentrations and CHD risk. 10, 11 A higher incidence of CHD and hypertension in higher latitudes, with less sunlight, has been identified in the results of previous studies. For instance, those with lower exposure to ultraviolet light and, hence, a lower 25OHD concentration may have a higher risk of heart disease, CHD, myocardial infarction, and hypertension. 12<15 An association between 25OHD and CHD could therefore be particularly relevant to older women who are at risk for 25OHD deficiency due to an age-associated decline in skin photoisomerization of 7-dehydrocholesterol 16 and decreased dietary intake of vitamin D 3 . Additional risk factors for 25OHD deficiency include living further from the equator, impaired hydroxylation, impaired renal function, and end organ insensitivity. 17<22 Most studies investigating the association between plasma 25OHD concentrations and CHD in human subjects are retrospective observational studies. The study presented here uses a cross-sectional study design of cynomolgus monkeys in which oral vitamin D 3 intake, sun exposure, and activity level are controlled, whereas atherosclerosis extent and arterial remodeling are measured directly at the tissue level. The objective of this study, therefore, was to determine the relationships between 25OHD 3 , CRP, coronary artery atherosclerosis, and coronary artery remodeling.
METHODS

Animals and diets
Adult female cynomolgus monkeys (Macaca fascicularis; n = 74) were used for this study. The monkeys were imported from Indonesia (Institute Pertanian Bogor), adult status was confirmed, and ages were estimated by epiphyseal closure and dentition. Upon arrival, monkeys underwent a 12-month preexperimental period, during which they received a controlled casein-lactalbumin (C/L) atherogenic diet. After this period, monkeys were randomized to a diet containing either soy or C/L as its main protein source. Both diets contained identical amounts of fat, carbohydrate, and protein per calorie of diet. The diets were equivalent in vitamin D 3 and calcium (women's equivalent, 1,000 IU/d and 1,200 mg/dl, respectively). The women's estimated equivalents were calculated by determining the amount of vitamin D 3 and calcium present in each 1,800 cal of diet and the assumption that the average woman consumes 1,800 cals per day. After consuming the diet for an additional 32 months, the monkeys underwent ovariectomy to induce surgical menopause. At this time, the monkeys were rerandomized to soy or C/L such that the premenopausal and postmenopausal dietary combinations included soy-soy, soy-C/ L, C/L-soy, or C/L-C/L. Monkeys consumed the diets for an additional 32 months postovariectomy. Body composition measurements were obtained at ovariectomy and at necropsy. An adiposity index for the monkeys was derived by measuring body weight by trunk length, and has a normal range of 35 to 55 kg/m 2 . Trunk length is measured from the sternal notch to the pubic symphysis.
All procedures involving animals in this study were conducted in compliance with the state and federal laws, standards of the US Department of Health and Human Services, and guidelines established by the Institutional Animal Care and Use Committee of the Wake Forest University, where the animals were housed.
CRP measurement
CRP was measured before and 32 months after ovariectomy. Serum CRP was determined by enzyme-linked immunosorbent assay using a human-based assay from ALPCO Diagnostics (Salem, NH). Intra-assay and interassay coefficients of variation were less than 10%.
25OHD 3 measurement
Plasma 25OHD 3 concentrations were measured in all 74 female cynomolgus monkeys 32 months after ovariectomy. All animals were housed indoors during the entire length of the study, minimizing any effect of sun exposure. All 25OHD assays were done at The Reading Hospital and Medical Center. Frozen samples (500 mL at j70-C) were transported to The Reading Hospital and Medical Center and protected from direct sunlight as per previously recommended techniques for yielding stable results. 23 The samples had never been thawed before the 25OHD assessments, and high-performance liquid chromatography/tandem mass spectrometry was used for the 25OHD assays (both 25OHD 2 and 25OHD 3 ). Our approach used the Shimadzu liquid chromatography-tandem mass spectrometry technology. The liquid chromatography-mass spectrometry process prepares the sample to be ionized, through physical separation capabilities of liquid chromatography, for mass analysis by injection into the AB Sciex 3200 Q Trap mass spectrometer. Vitamin D was provided in the diet as vitamin D 3 , so all analyses were done with plasma concentrations of 25OHD 3 .
Coronary artery atherosclerosis
At necropsy, the coronary arteries were perfusion fixed with 10% neutral buffered formalin at a pressure of 100 mm Hg. The left anterior descending (LAD), left circumflex (LCX), and right coronary (RCA) arteries were evaluated histomorphometrically to determine both plaque thickness (maximal intimal thickness [MXIT]) and plaque area (intimal area [IA]) as described previously. 24, 25 The mean MXIT and IA for each of the three coronary arteries were then determined, and the outcome variable for each was reported and analyzed, independently, as coronary artery atherosclerosis.
Coronary artery remodeling
After determining the degree of coronary artery atherosclerosis, as described above, the degree of coronary artery remodeling was assessed. The remodeling process, in which luminal area increases as arterial plaque size increases, has been described previously for both human subjects and macaques. 24 In this study, remodeling was assessed by comparing the coronary artery plaque size with the luminal area. The degree of coronary artery remodeling was assessed by comparing the plaque sizeYtoYartery size ratio, plaque sizeYtoYluminal area ratio, and luminal areaYtoYartery size ratio in the three coronary arteries.
Relationships among 25OHD 3 , CRP, and atherosclerosis
The relationships between CRP changes and coronary artery atherosclerosis among all three coronary arteries were determined. The relationships between 25OHD 3 and CRP at necropsy and the relationship between 25OHD 3 and the percentage change, as well as absolute change, in CRP during the postmenopausal phase were investigated. We analyzed those with high (Q the mean) and low (G the mean) plasma concentrations of 25OHD 3 along with high (Q the mean) and low (G the mean) plasma CRP concentrations. Using these parameters, we compared those with high 25OHD 3 /low CRP, high 25OHD 3 /high CRP, low 25OHD 3 /low CRP, and low 25OHD 3 /high CRP. Moreover, hypothesizing that those with high 25OHD 3 /low CRP would have the lowest degree of coronary artery atherosclerosis, we studied this group compared with all the others combined.
Statistical analysis
Body weight data are presented as means and SDs. 25OHD 3 concentrations were assessed for normality of distribution and were treated as continuous variables. Subjects were dichotomized into high and low 25OHD 3 concentration groups based on the determined mean concentration of 25OHD 3 . Each parameter of interest was compared between two 25OHD 3 concentration groups either by Student's t test or Mann-Whitney U test depending upon whether data were normally distributed. For assessment of the correlation between the demographic variables and 25OHD 3 concentrations of the entire cohort (n = 74), Pearson's correlation was used for normally distributed continuous variables; and Spearman ranked correlation, for nonnormally distributed variables. Correlations between CRP and 25OHD 3 concentrations (considered as both categorical [high vs low] and continuous variables) were analyzed using Spearman ranked correlation. Multiple linear regression analysis was used to assess predictive relationships between 25OHD 3 concentrations and each parameter of interest. All comparisons were done at both the end of menopause (at necropsy) and for the postmenopausal period (ovariectomy to necropsy). SAS 9.2 was used for all analyses, and a value of P G 0.05 was used to determine statistical significance.
During the construction of Figure 3 , comparing CRP and coronary artery atherosclerosis as a continuous variable, there was one atherosclerosis data point that was noted to be an outlier value for the IA parameters. The data point was more than 10 times higher than the other values. Although this value was determined to be a true value, the inclusion in the figure made the graphic representation difficult. Although the value was included in the results and data analysis, this subject was excluded from Figure 3 to eliminate a disproportionate scale. Examination of analytic results was performed; however, and the P value remained unchanged after elimination of this outlier value.
RESULTS
Of the 74 monkeys, 39 consumed the C/L diet and 35 consumed the soy diet during the premenopausal phase (baseline to ovariectomy). During the postmenopausal phase (ovariectomy to necropsy), 38 consumed the C/L diet and 36 consumed the soy diet. At the end of the postmenopausal life phase, plasma 25OHD 3 concentrations ranged from 1.4 to 102 ng/mL, with a mean of 48.9 T 16.6 ng/mL. The estimated mean age was 21.5 T 3.2 years, the mean weight was 3.4 T 0.7 kg, and the Table 1 for additional demographic information.
After being postmenopausal for 32 months, monkeys with a higher plasma 25OHD 3 concentration (ie, Q the mean) had significantly lower CRP concentrations than did the group with low 25OHD 3 (750.6 T 698.1 ng/mL vs 1,042.3 T 994.4 ng/mL, respectively; P = 0.04; effect size Cohen d = j0.36; Fig. 1) . Similarly, the continuous data also show a significant inverse relationship between plasma 25OHD 3 and serum CRP at necropsy (r = j0.35, P = 0.003; Fig. 2A ). When controlling for the postmenopausal diet (soy vs C/L) in a multiple linear regression analysis, this relationship was unchanged (adjusted R 2 = 0.15, P = 0.0004). The relationship between the percentage change in CRP from the end of the premenopausal period until the end of the postmenopausal period (32 months) and 25OHD 3 concentrations was also inverse (r = j0.32, P = 0.006; Fig. 2B ). When controlling for the postmenopausal diet (soy vs C/L) in a multiple linear regression analysis, the relationship was again unchanged (adjusted R 2 = 0.20, P G 0.0001). Similarly, as the plasma concentration of 25OHD 3 increased, the absolute increase in CRP was significantly lower (r = j0.31, P = 0.007). Again, when we controlled for the postmenopausal diet (soy vs C/L) in a multiple linear regression analysis, this relationship was still significant (adjusted R 2 = 0.19, P = 0.0006).
As the absolute CRP increased, atherosclerotic plaque area (IA) and MXIT were increased in all three main coronary arteries (LAD, LCX, and RCA) ( Fig. 3 ). LAD atherosclerosis extent was decreased in monkeys with high plasma 25OHD 3 concentrations (in the upper half of the mean) and low CRP change (in the lower half of the mean) compared with all other monkeys (those without high 25OHD 3 and low CRP change; P = 0.03, Cohen d = 0.50, Fig. 4 ). This relationship was also observed with plaque size (MXIT) in the RCA (P = 0.04, Cohen d = 0.58) but not in the LAD or LCX.
We also observed the usual association between the ratio of mean lumen area to mean IA (plaque size) of the LCX, LAD, and RCA. As coronary artery plaque size (IA) increased, there was a significant association with increases in the lumen area of all three main coronary arteries (LCX, r = 0.57, P G 0.0001; LAD, r = 0.55, P G 0.0001; RCA, r = 0.25, P = 0.0355), indicative of artery remodeling. However, remodeling seemed to be compromised in monkeys that experienced an increase in CRP concentration during the menopausal years. CRP was positively associated with the IAYtoYartery size ratios of the LCX, LAD, and RCA. This finding represents a consistent finding, in all three main coronary arteries, of a correlation between a greater absolute increase in CRP during the menopausal years and a significant compromise in coronary artery remodeling (LCX, r = 0.32, P = 0.007; LAD, r = 0.32, P = 0.007; RCA, r = 0.33, P = 0.005). Finally, we showed that the absolute change in CRP was inversely related to the luminal areaYtoYartery size ratio for all three main coronary arteries (LAD, LCX, and RCA). This again confirmed enhanced coronary artery remodeling with a lower CRP increase during menopause (Fig. 5 ).
DISCUSSION
The results of our study demonstrate an inverse relationship between plasma concentrations of 25OHD 3 and CRP. The association was apparent both when considering 25OHD 3 as a continuous variable and when comparing higher versus lower 25OHD 3 plasma concentrations. We also demonstrated that higher CRP concentrations, as well as increasing CRP concentrations during the menopause, were associated with greater coronary atherosclerosis.
What does the identified relationship between 25OHD 3 and CRP in our study mean? Certainly, CRP is an acute-phase reactant and, as such, has been shown to rise dramatically during inflammatory processes occurring in the human body. 26, 27 Current research has demonstrated that these markers play significant roles in a variety of acute and chronic diseases including infections, systemic inflammatory processes, tissue injury, hypertension, the metabolic syndrome, and most notably, CHD. 26, 27 25OHD 3 has been recognized as an immune modulator that may suppress proinflammatory cytokine expression and regulate immune cell activity. 28, 29 In addition, it is believed that vitamin D 3 supplementation may be associated with a reduction in proinflammatory cytokines in patients with heart failure. 30 It is important to note that this study was not designed to assess the effects of differential vitamin D supplementation, as all animals received equivalent levels of vitamin D 3 in their diet. Individual variation in circulating 25OHD 3 is probably caused, in part, by genetic determinants and responses to atherogenic diets, which may influence absorption and degradation in the liver, kidney, and elsewhere. Because CRP is produced by the liver, it is possible that the inverse relationship between 25OHD 3 and CRP is related to hepatic function and that hepatic inflammation causes increased 25OHD 3 turnover. More work needs to be done to explore these potential mechanisms. While there is some evidence to suggest that 25OHD deficiency may be associated with higher rates of cardiovascular disease, 10, 11, 31 well-designed prospective data to support this belief are lacking. 8 In addition, at least one recent randomized study did not show that vitamin D 3 supplementation changed circulating cytokine levels among healthy adults. 32 Some of the best data available, in fact, have also not been consistent with a cardioprotective role with regard to 25OHD. For example, data from the Women's Health Initiative, analyzing 36,282 postmenopausal women randomized to calcium and vitamin D 3 supplementation, were recently published. 33 This study suggested that calcium and vitamin D 3 supplementation was not associated with a risk of coronary or 5. A correlation between the luminal area-to-artery size ratio of the LAD and the absolute increase in CRP during the menopausal years is shown. This represents a direct correlation between a greater absolute increase in CRP during the menopausal years and a significantly greater decrease in luminal area-to-artery size ratio, representing a compromise in coronary artery remodeling (LAD, r = -0.32, P = 0.007). LAD, left anterior descending coronary artery; ASize, Artery size; LA, luminal area; CRP, C-reactive protein.
FIG. 3.
A correlation between the plaque area of the LAD and the absolute increase in CRP during the 32 month postmenopausal period is shown. A direct correlation between a greater absolute increase in CRP during the menopausal years and significantly greater amounts of coronary artery atherosclerosis, as measured by coronary artery plaque intimal area, was observed (LAD, r = 0.29, P = 0.015). LAD, left anterior descending coronary artery; CRP, C-reactive protein.
cerebrovascular events in generally healthy postmenopausal women over a 7-year period. Because of the limitations of the study, however, it is still premature to draw definitive conclusions based on these findings. Although these data are from a prospective trial, it was originally designed to evaluate the effects of calcium and vitamin D 3 supplementation on fracture, not cardiovascular disease. In addition, the dose of vitamin D 3 (400 IU daily) might be inadequate and insufficient to achieve optimal plasma 25OHD 3 concentrations. 33, 34 In addition, the proportion of women with coexisting hypertension at baseline was significantly higher in the vitamin D 3 supplementation group. Because clinical evidence of 25OHD as a protective factor for cardiovascular disease in postmenopausal women is limited, additional data on potential mechanisms for cardioprotection are necessary. The inverse relationship between plasma 25OHD 3 and CRP observed here suggests either an anti-inflammatory, and perhaps cardioprotective, effect of 25OHD 3 or a potential explanation, that is, systemic inflammation, for a low 25OHD 3 concentration in those with cardiovascular disease.
Even though a direct causal relationship between elevated CRP and coronary artery atherosclerosis in human subjects has not been proven, CRP is nevertheless frequently used in CHD risk assessment algorithms. 9,35<37 Not shown previously, for either human or nonhuman primates, is an association between coronary artery remodeling and plasma CRP concentrations. Despite the difficulty proving this in human cohorts, we were able to document that the increase in CRP over time, and during the menopausal years, correlated with extent of coronary artery atherosclerosis. We found that those with the highest plasma 25OHD 3 concentrations and the lowest increase in CRP over time, as expected, were afforded the greatest protection against coronary artery atherosclerosis. We also determined that those with the smallest increases in CRP during the menopausal period had the greatest degree of coronary artery remodeling, a finding consistent with decreased risk for CHD and cardiovascular events. 24 Clearly, we have shown strong evidence that lower plasma concentrations of 25OHD 3 are associated with higher systemic inflammation, as measured by CRP, and this in turn is associated with greater coronary artery atherosclerosis and worsening coronary artery remodeling. Therefore, 25OHD 3 , could play a cardioprotective role, as evidenced by the reduction of this marker, or may at least indicate a less atherogenic milieu. In addition to identifying and correlating a direct association between 25OHD 3 and coronary artery atherosclerosis, the correlation with other disease entities, as listed above, could also prove beneficial through future prospective trials.
The limitations to this study include the following. This cynomolgus monkey model has proven to be effective in studying menopause-related chronic diseases, particularly cardiovascular disease, 38 however, the relationships identified in this study may not be the same as those in human beings; hence, further studies in human cohorts are needed. The small sample size in our monkey cohort may have contributed to a type 2 error, limiting the identification of further significant relationships. Although it is possible that the various dietary regimens could have affected the inflammatory markers, we demonstrated that the source of dietary protein had no effect on the plasma concentrations of 25OHD 3 . In addition, regression analyses controlling for the diets revealed that the dietary changes did not alter the significant associations between 25OHD 3 and CRP. Because we do not definitively know the change in 25OHD 3 concentration over the course of the study, we cannot conclusively determine whether inflammation leads to reduced 25OHD 3 or whether higher 25OHD 3 leads to reduced inflammation. We believe that it is highly improbable, however, that the plasma 25OHD 3 concentrations in these monkeys varied significantly over time because of the strict control over their dietary vitamin D 3 and their environment, both of which remained constant during the experiment. In addition, because genetic factors are probably responsible for at least some of the observed variations in 25OHD 3 concentrations, it is plausible that these same factors may be influencing CRP concentrations. Therefore, despite our data showing a clear association between 25OHD 3 and CRP, further prospective data will be needed to clarify this relationship along with the temporal association.
Advantages of the nonhuman primate model include the ability to control for many of the confounding variables in human studies, including diet, vitamin D 3 intake, sun exposure, and general compliance. Additional strengths include the elimination of various confounding factors existing in human studies such as coexisting medical conditions (ie, type II diabetes), which has been linked to elevations in proinflammatory markers, especially CRP, 28 and concurrent hormone therapy, which has been associated with increased CRP concentrations. 39 Other confounding factors include exogenous vitamin D 3 / calcium or other supplementation (known or unknown) along with exercise, which has been associated with decreased inflammatory markers including CRP. 40 For these reasons, observed findings in this model may yield results that are less biased than those in human cohorts. It will be beneficial, therefore, to examine these findings in the general postmenopausal population.
CONCLUSIONS
We have identified a significant inverse correlation between 25OHD 3 and the inflammatory marker CRP. This increase in CRP was likewise correlated with a greater degree of coronary artery atherosclerosis and inhibited coronary artery remodeling. This association was strong and independent of any of the menopausal dietary changes. These findings suggest that circulating 25OHD 3 concentrations are associated with an antiinflammatory state. These findings support previous suggestions that higher 25OHD 3 concentrations may result in cardiovascular protection. Further investigations are required to determine the mechanism behind these relationships.
